The Australian advantage
360biolabs is an expert contract service provider supporting preclinical and clinical R&D from dedicated, world-class laboratory facilities located at the Burnet Institute in Melbourne, Australia.
Advantages of conducting studies in Australia:
- R&D Tax Incentive: up to $0.435 returned for every $1.00 spent
- Available to foreign owned entities
- The Clinical Trial Notification (CTN) Scheme provides fast, pragmatic review and approval by Australian Ethics Committees (IRBs) for Phase 1-2 studies
- 4-8 weeks for review and less than 12 weeks from submission to approval
- Reduced time and cost
- High quality healthcare system and clinical trial facilities
- Largely urbanised diverse population
- Strong, established CRO, logistics and laboratory networks
- Internationally recognised quality systems
- NATA: the world’s first and most experienced laboratory accreditation body
- Data accepted for filing by the FDA, EMA and other authorities worldwide
- World class Key Opinion Leaders